Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma (Q43296875)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2010

edit

Language	Label	Description	Also known as
English	Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma	scientific article published in January 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

title

Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

author name string

Brendon G Conry

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

Nikolaos D Papathanasiou

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

Vineet Prakash

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

Irfan Kayani

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

Martyn Caplin

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

Shahid Mahmood

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

Jamshed B Bomanji

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

publication date

1 January 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

published in

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

volume

37

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

page(s)

49-57

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

cites work

Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of medullary thyroid carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary thyroid cancer: monitoring and therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for Central and Bilateral Lymph Node Dissection in Sporadic and Hereditary Medullary Thyroid Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic and receptor imaging of metastatic medullary thyroid cancer: does anti-CEA and somatostatin-receptor scintigraphy allow for prognostic predictions?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging of neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrated PET/CT: current applications and future directions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of PET in medullary thyroid carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662413

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00259-009-1204-Z

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

Fatcat ID

release_e3iiunfjcbatbdvdtyrpldyvxi

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/e3iiunfjcbatbdvdtyrpldyvxi

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

19662413

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19662413

retrieved

18 November 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43296875&oldid=2205946923"